{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T13:58:56Z","timestamp":1761919136836},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1007\/s00535-008-2222-5","type":"journal-article","created":{"date-parts":[[2008,9,19]],"date-time":"2008-09-19T13:50:16Z","timestamp":1221832216000},"page":"711-719","source":"Crossref","is-referenced-by-count":42,"title":["Efficacy of combination therapy of antiviral and immunosuppressive drugs for the treatment of severe acute exacerbation of chronic hepatitis B"],"prefix":"10.1007","volume":"43","author":[{"given":"Keiichi","family":"Fujiwara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin","family":"Yasui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Yonemitsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Fukai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Arai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumio","family":"Imazeki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohito","family":"Sadahiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeto","family":"Oda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Yokosuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,9,20]]},"reference":[{"key":"2222_CR1","doi-asserted-by":"crossref","unstructured":"Editorial. Chemotherapy and hepatitis B. Lancet 1989;ii:1136\u20131137.","DOI":"10.1016\/S0140-6736(89)91495-5"},{"key":"2222_CR2","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1002\/(SICI)1097-0142(19961115)78:10<2210::AID-CNCR24>3.0.CO;2-0","volume":"78","author":"Y. Nakamura","year":"1996","unstructured":"Nakamura Y, Motokura T, Fujita R, Yamashita T, Ogata E. Severe hepatitis related to chemotherapy in hepatitis B virus carriers with hematologic malignancies. Cancer 1996;78:2210\u20132215.","journal-title":"Cancer"},{"key":"2222_CR3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.iy.13.040195.000333","volume":"13","author":"F.V. Chisari","year":"1995","unstructured":"Chisari FV, Ferrari C. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 1995;13:29\u201360.","journal-title":"Annu Rev Immunol"},{"key":"2222_CR4","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/hep.1840070328","volume":"7","author":"M.H. Sjogren","year":"1987","unstructured":"Sjogren MH, Hoofnagle JH, Waggoner JG. Effect of corticosteroid therapy on levels of antibody to hepatitis B core antigen in patients with chronic type B hepatitis. Hepatology 1987;7:582\u2013585.","journal-title":"Hepatology"},{"key":"2222_CR5","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1056\/NEJM198102123040702","volume":"304","author":"K.C. Lam","year":"1981","unstructured":"Lam KC, Lai CL, Trepo C, Wu PC. Deleterious effect of prednisolone in HBsAg-positive chronic active hepatitis. N Engl J Med 1981;304:380\u2013386.","journal-title":"N Engl J Med"},{"key":"2222_CR6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.7326\/0003-4819-104-1-12","volume":"104","author":"J.H. Hoofnagle","year":"1986","unstructured":"Hoofnagle JH, Davis GL, Pappas SC, Hanson RG, Peters M, Avigan MI, et al. A short course of prednisolone in chronic type B hepatitis. Ann Intern Med 1986;104:12\u201317.","journal-title":"Ann Intern Med"},{"key":"2222_CR7","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0016-5085(81)80002-9","volume":"81","author":"G.H. Scullard","year":"1981","unstructured":"Scullard GH, Smith CI, Merigan TC, Robinson WS, Gregory PB. Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B. Gastroenterology 1981;81:987\u2013991.","journal-title":"Gastroenterology"},{"key":"2222_CR8","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/0140-6736(91)91433-U","volume":"337","author":"J.Y. Lau","year":"1991","unstructured":"Lau JY, Bird GL, Gimson AE, Alexander GJ, Williams R. Treatment of HBV reactivation after withdrawal of immunosuppression. Lancet 1991;337:802.","journal-title":"Lancet"},{"key":"2222_CR9","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.3748\/wjg.v11.i8.1109","volume":"11","author":"K. Fujiwara","year":"2005","unstructured":"Fujiwara K, Yokosuka O, Kojima H, Kanda T, Saisho H, Hirasawa H, et al. Importance of adequate immunosuppressive therapy for the recovery of patients with \u201clife-threatening\u201d severe exacerbation of chronic hepatitis B. World J Gastroenterol 2005;11:1109\u20131114","journal-title":"World J Gastroenterol"},{"key":"2222_CR10","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0168-8278(99)80119-6","volume":"30","author":"T. Santantonio","year":"1999","unstructured":"Santantonio T, Mazzola M, Pastore G. Lamivudine is safe and effective in fulminant hepatitis B. J Hepatol 1999;30:551\u2013553.","journal-title":"J Hepatol"},{"key":"2222_CR11","first-page":"808","volume":"44","author":"D.H. Thiel Van","year":"1997","unstructured":"Van Thiel DH, Friedlander L, Kania RJ, Molloy PJ, Hassanein T, Wahlstrom E, et al. Lamivudine treatment of advanced and decompensated liver disease due to hepatitis B. Hepatogastroenterology 1997;44:808\u2013812.","journal-title":"Hepatogastroenterology"},{"key":"2222_CR12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0016-5085(98)70380-4","volume":"115","author":"T.M. Chan","year":"1998","unstructured":"Chan TM, Wu PC, Li FK, Lai CL, Cheng IK, Lai KN. Treatment of fibrosing cholestatic hepatitis with lamivudine. Gastroenterology 1998;115:177\u2013181.","journal-title":"Gastroenterology"},{"key":"2222_CR13","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1023\/A:1026622807373","volume":"43","author":"F. Borg ter","year":"1998","unstructured":"ter Borg F, Smorenburg S, de Man RA, Rietbroek RC, Chamuleau RA, Jones EA. Recovery from life-threatening corticosteroid-unresponsive chemotherapy-related reactivation of hepatitis B associated with lamivudine therapy. Dig Dis Sci 1998;43:2267\u20132270.","journal-title":"Dig Dis Sci"},{"key":"2222_CR14","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1572-0241.1999.00808.x","volume":"94","author":"A. Ahmed","year":"1999","unstructured":"Ahmed A, Keeffe EB. Lamivudine therapy for chemotherapyinduced reactivation of hepatitis B virus infection. Am J Gastroenterol 1999;94:249\u2013251.","journal-title":"Am J Gastroenterol"},{"key":"2222_CR15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/hep.510310130","volume":"31","author":"J.P. Villeneuve","year":"2000","unstructured":"Villeneuve JP, Condreay LD, Willems B, Pomier-Layrargues G, Fenyves D, Bilodeau M, et al. Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B. Hepatology 2000;31:207\u2013210.","journal-title":"Hepatology"},{"key":"2222_CR16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1386-6346(00)00079-6","volume":"19","author":"S. Iino","year":"2001","unstructured":"Iino S, Tango T, Matsushima T, Toda G, Miyake K, Hino K, et al. Therapeutic effects of stronger neo-minophagen C at different doses on chronic hepatitis and liver cirrhosis. Hepatol Res 2001;19:31\u201340.","journal-title":"Hepatol Res"},{"key":"2222_CR17","first-page":"215","volume":"60","author":"H. Okamoto","year":"1990","unstructured":"Okamoto H, Okada S, Sugiyama Y, Tanaka T, Sugai Y, Akahane Y, et al. Detection of hepatitis C virus RNA by a two-step polymerase chain reaction with two pairs of primers deduced from the 5\u2032-noncoding region. Jpn J Exp Med 1990;60:215\u2013222.","journal-title":"Jpn J Exp Med"},{"key":"2222_CR18","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1128\/JVI.12.5.995-1005.1973","volume":"12","author":"P.M. Kaplan","year":"1973","unstructured":"Kaplan PM, Greenman RL, Gerin TL, Purcell RH, Robinson WS. DNA polymerase associated with human hepatitis B antigen. J Virol 1973;12:995\u20131005.","journal-title":"J Virol"},{"key":"2222_CR19","first-page":"2925","volume":"46","author":"S. Markovic","year":"1999","unstructured":"Markovic S, Drozina G, Vovk M, Fidler-Jenko M. Reactivation of hepatitis B but not hepatitis C in patients with malignant lymphoma and immunosuppressive therapy. A prospective study in 305 patients. Hepatogastroenterology 1999;46:2925\u20132930.","journal-title":"Hepatogastroenterology"},{"key":"2222_CR20","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/j.1872-034X.2008.00322.x","volume":"38","author":"K. Fujiwara","year":"2008","unstructured":"Fujiwara K, Mochida S, Matsui A, Nakayama N, Nagoshi S, Toda G; Intractable Liver diseases Study Group of Japan. Fulminant hepatitis and late onset hepatic failure in Japan. Hepatol Res 2008;38:646\u2013657.","journal-title":"Hepatol Res"},{"key":"2222_CR21","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1440-1746.2004.03534.x","volume":"20","author":"A. Tsubota","year":"2005","unstructured":"Tsubota A, Arase Y, Suzuki Y, Suzuki F, Sezaki H, Hosaka T, et al. Lamivudine monotherapy for spontaneous severe acute exacerbation of chronic hepatitis B. J Gastroenterol Hepatol 2005;20:426\u2013432.","journal-title":"J Gastroenterol Hepatol"},{"key":"2222_CR22","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1046\/j.1365-2893.2002.00385.x","volume":"9","author":"H.L. Chan","year":"2002","unstructured":"Chan HL, Tsang SW, Hui Y, Leung NW, Chan FK, Sung JJ. The role of lamivudine and predictors of mortality in severe flare-up of chronic hepatitis B with jaundice. J Viral Hepat 2002;9:424\u2013428.","journal-title":"J Viral Hepat"},{"key":"2222_CR23","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0168-8278(02)00419-1","volume":"38","author":"R.N. Chien","year":"2003","unstructured":"Chien RN, Lin CH, Liaw YF. The effect of lamivudine therapy in hepatic decompensation during acute exacerbation of chronic hepatitis B. J Hepatol 2003;38:322\u2013327.","journal-title":"J Hepatol"},{"key":"2222_CR24","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1073\/pnas.83.6.1627","volume":"83","author":"R. Tur-Kaspa","year":"1986","unstructured":"Tur-Kaspa R, Burk RD, Shaul Y, Shafritz DA. Hepatitis B virus DNA contains a glucocorticoid-responsive element. Proc Natl Acad Sci USA 1986;83:1627\u20131631.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2222_CR25","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1056\/NEJM197603252941301","volume":"294","author":"P.B. Gregory","year":"1976","unstructured":"Gregory PB, Knauer M, Kempson RL, Miller R. Steroid therapy in severe viral hepatitis. N Engl J Med 1976;294:681\u2013687.","journal-title":"N Engl J Med"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-008-2222-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-008-2222-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-008-2222-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T10:51:23Z","timestamp":1588935083000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-008-2222-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["2222"],"URL":"https:\/\/doi.org\/10.1007\/s00535-008-2222-5","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}